Aimei Health extends SPAC merger deadline to Oct 6

Q: What did AFJK disclose about its latest SPAC extension on September 3, 2026?

Aimei Health Technology Co., Ltd. extended the deadline to complete its initial business combination by one month to October 6, 2026 by depositing $34,330.96 into its trust account, consistent with the extension terms in its governing documents.

Q: How much did AFJK contribute to the trust account for this extension?

AFJK deposited $34,330.96 into its trust account. This amount equals the lesser of $80,000 for all outstanding public shares and $0.033 per outstanding public share for the one-month extension period.

Q: What are the key terms of AFJK’s $34,330.96 Promissory Note?

AFJK issued an unsecured Promissory Note for $34,330.96 to Aimei Investment Ltd. It bears no interest and the principal is due upon completion of the business combination with United Hydrogen.

Aimei Health Technology Co., Ltd. (AFJK) extended the deadline to complete its initial business combination by one month, making a payment of $34,330.96 into its trust account to move the Termination Date from September 6, 2026 to October 6, 2026.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Aimei Health Technology Co., Ltd. (AFJK) extended the deadline to complete its initial business combination by one month, making a payment of $34,330.96 into its trust account to move the Termination Date from September 6, 2026 to October 6, 2026. This amount represents the lesser of $80,000 for all outstanding public shares and $0.033 per outstanding public share for the monthly extension and is the 22nd extension permitted under its Amended and Restated Articles of Association.

To fund the extension payment, the company issued an unsecured Promissory Note for $34,330.96 to Aimei Investment Ltd. The note bears no interest and becomes due upon consummation of the planned business combination with United Hydrogen. The payee may convert the note into private units at $10.00 per unit, each unit consisting of one ordinary share and one right to receive one-fifth of one ordinary share, immediately prior to closing by giving two business days’ written notice.

8-K Event Classification

2 items: 2.03, 9.01

2 items

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial

The company incurred a new significant debt or off-balance-sheet obligation.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Extension Payment: $34,330.96 Per-share monthly extension amount: $0.033 per outstanding public share Alternative extension cap: $80,000 +5 more

8 metrics

Extension Payment $34,330.96 Amount deposited into the trust account for the one-month extension

Per-share monthly extension amount $0.033 per outstanding public share Used to determine the monthly extension payment

Alternative extension cap $80,000 Maximum aggregate amount compared against per-share formula for the extension

Promissory Note principal $34,330.96 Unsecured note issued to Aimei Investment Ltd to fund the extension

Conversion price per private unit $10.00 per unit Price at which the Promissory Note may be converted into private units

Extension sequence 22nd extension Number of monthly extensions used under the company’s Articles of Association

Original Termination Date September 6, 2026 Deadline before this one-month extension

New Termination Date October 6, 2026 Revised deadline to consummate the initial business combination

Key Terms

trust account, Promissory Note, Termination Date, business combination, +1 more

5 terms

trust account financial

"has been deposited into the trust account of Aimei Health Technology Co., Ltd"

A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.

Promissory Note financial

"the Company issued, on September 3, 2026, an unsecured promissory note"

A promissory note is a written IOU in which one party promises to pay a specific sum, often with interest, to another party by a set date or on demand. Investors care because it functions like a loan: it creates a legal claim on future cash flows, carries credit and timing risk, and can affect valuation or liquidity—think of it as a formal, tradable promise to be repaid that can be assessed like any other debt investment.

Termination Date financial

"by one month from September 6, 2026 to October 6, 2026 (the “Termination Date”)"

Termination date is the specific calendar day when a contract, agreement, option or other legal arrangement stops being in effect and any remaining rights or obligations expire. For investors it matters because that date sets deadlines for exercising rights, receiving payments, closing positions or avoiding penalties—similar to the day a lease or warranty ends, after which parties no longer have the same protections or claims.

business combination financial

"the period of time it has to consummate its initial business combination"

A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.

private units financial

"convert the Promissory Note, in whole or in part, into private units of the Company"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AFJK disclose about its latest SPAC extension on September 3, 2026?

Aimei Health Technology Co., Ltd. extended the deadline to complete its initial business combination by one month to October 6, 2026 by depositing $34,330.96 into its trust account, consistent with the extension terms in its governing documents.

How much did AFJK contribute to the trust account for this extension?

AFJK deposited $34,330.96 into its trust account. This amount equals the lesser of $80,000 for all outstanding public shares and $0.033 per outstanding public share for the one-month extension period.

What is the new Termination Date for AFJK’s initial business combination?

The Termination Date to complete AFJK’s initial business combination was extended from September 6, 2026 to October 6, 2026, marking the 22nd extension under its Amended and Restated Articles of Association.

What are the key terms of AFJK’s $34,330.96 Promissory Note?

AFJK issued an unsecured Promissory Note for $34,330.96 to Aimei Investment Ltd. It bears no interest and the principal is due upon completion of the business combination with United Hydrogen.

Can the AFJK promissory note be converted into equity and on what terms?

Yes. Aimei Investment Ltd may convert the Promissory Note, in whole or in part, into private units at $10.00 per unit, each unit including one ordinary share and a right to receive one-fifth of one ordinary share, by giving two business days’ written notice before closing.

Who is the counterparty to AFJK’s business combination referenced in this filing?

The filing states that the principal under the Promissory Note becomes due when AFJK consummates a business combination with United Hydrogen, which is the named counterparty to the planned business combination.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/03/2026 - 08:01 AM EDT Accepted by SEC EDGAR 09/03/2026 - 08:00 AM EDT

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

September 3, 2026

Date of Report (Date of earliest event reported)

AIMEI HEALTH TECHNOLOGY CO., LTD

(Exact Name of Registrant as Specified in its Charter)

Cayman Islands

001-41880

00-0000000N/A

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

10 East 53rd Street, Suite 3001

New York, NY

10022

(Address of Principal Executive Offices)

(Zip Code)

86-13758131392

Registrant’s telephone number, including area code

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class	Trading Symbol(s)	Name of each exchange on which registered
Ordinary Shares, par value $0.0001 per share	AFJK	The Nasdaq Stock Market LLC
Rights, exchangeable into one-fifth of one Ordinary Share	AFJKR	The Nasdaq Stock Market LLC
Units, each consisting of one Ordinary Share and one Right	AFJKU	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

Extension of the Termination Date

An aggregate of $34,330.96 (the “Extension Payment”) has been deposited into the trust account of Aimei Health Technology Co., Ltd (the “Company”) for its public shareholders, representing the lesser of (i) $80,000 for all outstanding public shares and (ii) $0.033 for each outstanding public share for each monthly extension, which enables the Company to further extend the period of time it has to consummate its initial business combination by one month (the “Extension”) from September 6, 2026 to October 6, 2026 (the “Termination Date”). The Extension is the 22nd extension permitted under the Amended and Restated Articles of Association of the Company currently in effect.

Promissory Note

In connection with the Extension, the Company issued, on September 3, 2026, an unsecured promissory note in the total principal amount of $34,330.96 (the “Promissory Note”) to Aimei Investment Ltd, a Cayman Islands exempted company (the “Payee”), to fund the Extension Payment. The Promissory Note does not bear interest and the principal thereunder becomes due and payable upon the date on which the Company consummates a business combination with United Hydrogen (the “Business Combination”). The Payee has the right, but not the obligation, to convert the Promissory Note, in whole or in part, into private units of the Company, at a price of $10.00 per unit, each consisting of one ordinary share and one right to receive one-fifth (1/5) of one ordinary share of the Company, immediately prior to the consummation of the Business Combination, by providing the Company with written notice of its intention to convert the Promissory Note at least two business days prior to the closing of the Business Combination.

The foregoing description of the Promissory Note is not complete and is qualified in its entirety by reference to the text of such document, which is filed as Exhibit 10.1 hereto and which is incorporated herein by reference.

Item 9.01 Exhibits.

(d) Exhibits

Exhibit No.		Description
10.1		Promissory Note, dated September 3, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 3, 2026

	Aimei Health Technology Co., Ltd

	By:	/s/ Junheng Xie
	Name:	Junheng Xie
	Title:	Chief Executive Officer and Director
		(Principal Executive Officer)

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

5 documents

Agreements & Contracts

EX-10.1 EX-10.1 43.0 KB